TY - JOUR PY - 2005 DA - 2005// TI - Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67394-1 DO - 10.1016/S0140-6736(05)67394-1 ID - ref1 ER - TY - JOUR PY - 2010 DA - 2010// TI - Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61350-5 DO - 10.1016/S0140-6736(10)61350-5 ID - ref2 ER - TY - JOUR PY - 2012 DA - 2012// TI - Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0029849 DO - 10.1371/journal.pone.0029849 ID - ref3 ER - TY - JOUR PY - 2008 DA - 2008// TI - Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60104-X DO - 10.1016/S0140-6736(08)60104-X ID - ref4 ER - TY - JOUR PY - 2012 DA - 2012// TI - The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)60367-5 DO - 10.1016/S0140-6736(12)60367-5 ID - ref5 ER - TY - JOUR AU - Gansevoort, R. T. AU - Correa-Rotter, R. AU - Hemmelgarn, B. R. AU - Jafar, T. H. AU - Heerspink, H. J. AU - Mann, J. F. AU - Matsushita, K. AU - Wen, C. P. PY - 2013 DA - 2013// TI - Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)60595-4 DO - 10.1016/S0140-6736(13)60595-4 ID - Gansevoort2013 ER - TY - JOUR AU - Fellstrom, B. C. AU - Jardine, A. G. AU - Schmieder, R. E. AU - Holdaas, H. AU - Bannister, K. AU - Beutler, J. AU - Chae, D. W. AU - Chevaile, A. AU - Cobbe, S. M. AU - Gronhagen-Riska, C. PY - 2009 DA - 2009// TI - Rosuvastatin and cardiovascular events in patients undergoing hemodialysis JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0810177 DO - 10.1056/NEJMoa0810177 ID - Fellstrom2009 ER - TY - JOUR AU - Wanner, C. AU - Krane, V. AU - Marz, W. AU - Olschewski, M. AU - Mann, J. F. AU - Ruf, G. AU - Ritz, E. PY - 2005 DA - 2005// TI - Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa043545 DO - 10.1056/NEJMoa043545 ID - Wanner2005 ER - TY - JOUR PY - 2011 DA - 2011// TI - The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60739-3 DO - 10.1016/S0140-6736(11)60739-3 ID - ref9 ER - TY - JOUR PY - 2010 DA - 2010// TI - Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease JO - Am Heart J VL - 160 UR - https://doi.org/10.1016/j.ahj.2010.08.012 DO - 10.1016/j.ahj.2010.08.012 ID - ref10 ER - TY - JOUR AU - Law, M. AU - Rudnicka, A. R. PY - 2006 DA - 2006// TI - Statin safety: a systematic review JO - Am J Cardiol VL - 97 UR - https://doi.org/10.1016/j.amjcard.2005.12.010 DO - 10.1016/j.amjcard.2005.12.010 ID - Law2006 ER - TY - JOUR AU - Armitage, J. PY - 2007 DA - 2007// TI - The safety of statins in clinical practice JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)60716-8 DO - 10.1016/S0140-6736(07)60716-8 ID - Armitage2007 ER - TY - JOUR AU - Collins, R. AU - Reith, C. AU - Emberson, J. AU - Armitage, J. AU - Baigent, C. AU - Blackwell, L. PY - 2016 DA - 2016// TI - Interpretation of the evidence for the efficacy and safety of statin therapy JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31357-5 DO - 10.1016/S0140-6736(16)31357-5 ID - Collins2016 ER - TY - JOUR AU - Preiss, D. AU - Seshasai, S. R. AU - Welsh, P. AU - Murphy, S. A. AU - Ho, J. E. AU - Waters, D. D. AU - DeMicco, D. A. AU - Barter, P. AU - Cannon, C. P. AU - Sabatine, M. S. PY - 2011 DA - 2011// TI - Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis JO - JAMA VL - 305 UR - https://doi.org/10.1001/jama.2011.860 DO - 10.1001/jama.2011.860 ID - Preiss2011 ER - TY - JOUR AU - Sattar, N. AU - Preiss, D. AU - Murray, H. M. AU - Welsh, P. AU - Buckley, B. M. AU - Craen, A. J. AU - Seshasai, S. R. AU - McMurray, J. J. AU - Freeman, D. J. AU - Jukema, J. W. PY - 2010 DA - 2010// TI - Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61965-6 DO - 10.1016/S0140-6736(09)61965-6 ID - Sattar2010 ER - TY - JOUR PY - 2006 DA - 2006// TI - High-dose atorvastatin after stroke or transient ischemic attack JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061894 DO - 10.1056/NEJMoa061894 ID - ref16 ER - TY - JOUR AU - Hippisley-Cox, J. AU - Coupland, C. PY - 2010 DA - 2010// TI - Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database JO - BMJ VL - 340 UR - https://doi.org/10.1136/bmj.c2197 DO - 10.1136/bmj.c2197 ID - Hippisley-Cox2010 ER - TY - JOUR AU - Bjornsson, E. AU - Jacobsen, E. I. AU - Kalaitzakis, E. PY - 2012 DA - 2012// TI - Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing JO - J Hepatol VL - 56 UR - https://doi.org/10.1016/j.jhep.2011.07.023 DO - 10.1016/j.jhep.2011.07.023 ID - Bjornsson2012 ER - TY - JOUR AU - Dormuth, C. R. AU - Hemmelgarn, B. R. AU - Paterson, J. M. AU - James, M. T. AU - Teare, G. F. AU - Raymond, C. B. AU - Lafrance, J. P. AU - Levy, A. AU - Garg, A. X. AU - Ernst, P. PY - 2013 DA - 2013// TI - Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases JO - BMJ VL - 346 UR - https://doi.org/10.1136/bmj.f880 DO - 10.1136/bmj.f880 ID - Dormuth2013 ER - TY - JOUR AU - Evans, M. A. AU - Golomb, B. A. PY - 2009 DA - 2009// TI - Statin-associated adverse cognitive effects: survey results from 171 patients JO - Pharmacotherapy VL - 29 UR - https://doi.org/10.1592/phco.29.7.800 DO - 10.1592/phco.29.7.800 ID - Evans2009 ER - TY - JOUR AU - Takada, M. AU - Fujimoto, M. AU - Yamazaki, K. AU - Takamoto, M. AU - Hosomi, K. PY - 2014 DA - 2014// TI - Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database JO - Drug Saf VL - 37 UR - https://doi.org/10.1007/s40264-014-0163-x DO - 10.1007/s40264-014-0163-x ID - Takada2014 ER - TY - JOUR AU - Garde, E. M. AU - Hak, E. AU - Souverein, P. C. AU - Hoes, A. W. AU - Bosch, J. M. AU - Leufkens, H. G. PY - 2006 DA - 2006// TI - Statin treatment and reduced risk of pneumonia in patients with diabetes JO - Thorax VL - 61 UR - https://doi.org/10.1136/thx.2006.062885 DO - 10.1136/thx.2006.062885 ID - Garde2006 ER - TY - JOUR AU - Khan, A. R. AU - Riaz, M. AU - Bin Abdulhak, A. A. AU - Al-Tannir, M. A. AU - Garbati, M. A. AU - Erwin, P. J. AU - Baddour, L. M. AU - Tleyjeh, I. M. PY - 2013 DA - 2013// TI - The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0052929 DO - 10.1371/journal.pone.0052929 ID - Khan2013 ER - TY - JOUR AU - Atar, S. AU - Cannon, C. P. AU - Murphy, S. A. AU - Rosanio, S. AU - Uretsky, B. F. AU - Birnbaum, Y. PY - 2006 DA - 2006// TI - Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial JO - Am Heart J VL - 151 UR - https://doi.org/10.1016/j.ahj.2006.02.013 DO - 10.1016/j.ahj.2006.02.013 ID - Atar2006 ER - TY - JOUR AU - Wahner, A. D. AU - Bronstein, J. M. AU - Bordelon, Y. M. AU - Ritz, B. PY - 2008 DA - 2008// TI - Statin use and the risk of Parkinson disease JO - Neurology VL - 70 UR - https://doi.org/10.1212/01.wnl.0000286942.14552.51 DO - 10.1212/01.wnl.0000286942.14552.51 ID - Wahner2008 ER - TY - JOUR AU - Lee, Y. C. AU - Lin, C. H. AU - Wu, R. M. AU - Lin, M. S. AU - Lin, J. W. AU - Chang, C. H. AU - Lai, M. S. PY - 2013 DA - 2013// TI - Discontinuation of statin therapy associates with Parkinson disease: a population-based study JO - Neurology VL - 81 UR - https://doi.org/10.1212/WNL.0b013e31829d873c DO - 10.1212/WNL.0b013e31829d873c ID - Lee2013 ER - TY - JOUR AU - Chan, K. A. AU - Andrade, S. E. AU - Boles, M. AU - Buist, D. S. M. AU - Chase, G. A. AU - Donahue, J. G. AU - Goodman, M. J. AU - Gurwitz, J. H. AU - LaCroix, A. Z. AU - Platt, R. PY - 2000 DA - 2000// TI - Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02400-4 DO - 10.1016/S0140-6736(00)02400-4 ID - Chan2000 ER - TY - JOUR AU - Jager, D. J. AU - Grootendorst, D. C. AU - Jager, K. J. AU - Dijk, P. C. AU - Tomas, L. M. AU - Ansell, D. AU - Collart, F. AU - Finne, P. AU - Heaf, J. G. AU - Meester, J. PY - 2009 DA - 2009// TI - Cardiovascular and noncardiovascular mortality among patients starting dialysis JO - JAMA VL - 302 UR - https://doi.org/10.1001/jama.2009.1488 DO - 10.1001/jama.2009.1488 ID - Jager2009 ER - TY - STD TI - Inegy tablets; Summary of Product Characteristics. https://www.medicines.org.uk/emc/medicine/15657#PRODUCTINFO. Accessed 11 Apr 2017. UR - https://www.medicines.org.uk/emc/medicine/15657#PRODUCTINFO ID - ref29 ER - TY - JOUR PY - 2014 DA - 2014// TI - The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection JO - Clin J Am Soc Nephrol VL - 9 UR - https://doi.org/10.2215/CJN.10371013 DO - 10.2215/CJN.10371013 ID - ref30 ER - TY - JOUR AU - Besseling, J. AU - Kastelein, J. J. AU - Defesche, J. C. AU - Hutten, B. A. AU - Hovingh, G. K. PY - 2015 DA - 2015// TI - Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus JO - JAMA VL - 313 UR - https://doi.org/10.1001/jama.2015.1206 DO - 10.1001/jama.2015.1206 ID - Besseling2015 ER - TY - JOUR AU - Ference, B. A. AU - Robinson, J. G. AU - Brook, R. D. AU - Catapano, A. L. AU - Chapman, M. J. AU - Neff, D. R. AU - Voros, S. AU - Giugliano, R. P. AU - Davey Smith, G. AU - Fazio, S. PY - 2016 DA - 2016// TI - Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1604304 DO - 10.1056/NEJMoa1604304 ID - Ference2016 ER - TY - STD TI - Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, Hartwig FP, Horta BL, Hypponen E, Power C, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2017;5(2):97-105. doi:10.1016/S2213-8587(16)30396-5. ID - ref33 ER - TY - JOUR AU - Lotta, L. A. AU - Sharp, S. J. AU - Burgess, S. AU - Perry, J. R. AU - Stewart, I. D. AU - Willems, S. M. AU - Luan, J. AU - Ardanaz, E. AU - Arriola, L. AU - Balkau, B. PY - 2016 DA - 2016// TI - Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis JO - JAMA VL - 316 UR - https://doi.org/10.1001/jama.2016.14568 DO - 10.1001/jama.2016.14568 ID - Lotta2016 ER - TY - JOUR AU - Iribarren, C. PY - 1998 DA - 1998// TI - Cohort study of serum total cholesterol and in-hospital incidence of infectious diseases JO - Epidemiol Infect VL - 121 UR - https://doi.org/10.1017/S0950268898001435 DO - 10.1017/S0950268898001435 ID - Iribarren1998 ER - TY - JOUR AU - Iribarren, C. AU - Jacobs, D. R. AU - Sidney, S. AU - Claxton, A. J. AU - Gross, M. D. AU - Sadler, M. AU - Blackburn, H. PY - 1997 DA - 1997// TI - Serum total cholesterol and risk of hospitalization, and death from respiratory disease JO - Int J Epidemiol VL - 26 UR - https://doi.org/10.1093/ije/26.6.1191 DO - 10.1093/ije/26.6.1191 ID - Iribarren1997 ER - TY - JOUR AU - Frost, F. J. AU - Petersen, H. AU - Tollestrup, K. AU - Skipper, B. PY - 2007 DA - 2007// TI - Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins JO - Chest VL - 131 UR - https://doi.org/10.1378/chest.06-1997 DO - 10.1378/chest.06-1997 ID - Frost2007 ER - TY - JOUR PY - 2014 DA - 2014// TI - Rosuvastatin for sepsis-associated acute respiratory distress syndrome JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1401520 DO - 10.1056/NEJMoa1401520 ID - ref38 ER - TY - JOUR AU - Criner, G. J. AU - Connett, J. E. AU - Aaron, S. D. AU - Albert, R. K. AU - Bailey, W. C. AU - Casaburi, R. AU - Cooper, J. A. AU - Curtis, J. L. AU - Dransfield, M. T. AU - Han, M. K. PY - 2014 DA - 2014// TI - Simvastatin for the prevention of exacerbations in moderate-to-severe COPD JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1403086 DO - 10.1056/NEJMoa1403086 ID - Criner2014 ER - TY - JOUR AU - McAuley, D. F. AU - Laffey, J. G. AU - O’Kane, C. M. AU - Perkins, G. D. AU - Mullan, B. AU - Trinder, T. J. AU - Johnston, P. AU - Hopkins, P. A. AU - Johnston, A. J. AU - McDowell, C. PY - 2014 DA - 2014// TI - Simvastatin in the acute respiratory distress syndrome JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1403285 DO - 10.1056/NEJMoa1403285 ID - McAuley2014 ER - TY - JOUR AU - Fried, L. F. AU - Orchard, T. J. AU - Kasiske, B. L. PY - 2001 DA - 2001// TI - Effect of lipid reduction on the progression of renal disease: a meta-analysis JO - Kidney Int VL - 59 UR - https://doi.org/10.1046/j.1523-1755.2001.00487.x DO - 10.1046/j.1523-1755.2001.00487.x ID - Fried2001 ER - TY - JOUR AU - Zheng, Z. AU - Jayaram, R. AU - Jiang, L. AU - Emberson, J. AU - Zhao, Y. AU - Li, Q. AU - Du, J. AU - Guarguagli, S. AU - Hill, M. AU - Chen, Z. PY - 2016 DA - 2016// TI - Perioperative Rosuvastatin in Cardiac Surgery JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1507750 DO - 10.1056/NEJMoa1507750 ID - Zheng2016 ER - TY - JOUR PY - 2014 DA - 2014// TI - Effects of lowering LDL cholesterol on progression of kidney disease JO - J Am Soc Nephrol VL - 25 UR - https://doi.org/10.1681/ASN.2013090965 DO - 10.1681/ASN.2013090965 ID - ref43 ER - TY - JOUR AU - Bulbulia, R. AU - Bowman, L. AU - Wallendszus, K. AU - Parish, S. AU - Armitage, J. AU - Peto, R. AU - Collins, R. PY - 2011 DA - 2011// TI - Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)61125-2 DO - 10.1016/S0140-6736(11)61125-2 ID - Bulbulia2011 ER - TY - JOUR AU - Ford, I. AU - Murray, H. AU - McCowan, C. AU - Packard, C. J. PY - 2016 DA - 2016// TI - Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of west of Scotland coronary prevention study JO - Circulation VL - 133 UR - https://doi.org/10.1161/CIRCULATIONAHA.115.019014 DO - 10.1161/CIRCULATIONAHA.115.019014 ID - Ford2016 ER - TY - JOUR PY - 2016 DA - 2016// TI - Protocol for analyses of adverse event data from randomized controlled trials of statin therapy JO - Am Heart J VL - 176 UR - https://doi.org/10.1016/j.ahj.2016.01.016 DO - 10.1016/j.ahj.2016.01.016 ID - ref46 ER - TY - JOUR PY - 2014 DA - 2014// TI - Effects of extended-release niacin with laropiprant in high-risk patients JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1300955 DO - 10.1056/NEJMoa1300955 ID - ref47 ER - TY - JOUR AU - Cannon, C. P. AU - Blazing, M. A. AU - Giugliano, R. P. AU - McCagg, A. AU - White, J. A. AU - Theroux, P. AU - Darius, H. AU - Lewis, B. S. AU - Ophuis, T. O. AU - Jukema, J. W. PY - 2015 DA - 2015// TI - Ezetimibe added to statin therapy after acute coronary syndromes JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1410489 DO - 10.1056/NEJMoa1410489 ID - Cannon2015 ER - TY - STD TI - Merck Sharp and Dohme. IMPROVE-IT Study. Food and Drug Administration Endocrinologic and Metabolic Drug Products Advisory Committee Briefing Document. 2015. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM476506.pdf. Accessed 30 Mar 2016. UR - https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM476506.pdf ID - ref49 ER -